Champions Oncology Inc
NASDAQ:CSBR
Champions Oncology Inc
Income from Continuing Operations
Champions Oncology Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Champions Oncology Inc
NASDAQ:CSBR
|
Income from Continuing Operations
-$9.7m
|
CAGR 3-Years
-113%
|
CAGR 5-Years
-108%
|
CAGR 10-Years
-3%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Income from Continuing Operations
$6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Income from Continuing Operations
$7.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Income from Continuing Operations
$777.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Agilent Technologies Inc
NYSE:A
|
Income from Continuing Operations
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
1%
|
CAGR 10-Years
22%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
65%
|
CAGR 5-Years
42%
|
CAGR 10-Years
20%
|
See Also
What is Champions Oncology Inc's Income from Continuing Operations?
Income from Continuing Operations
-9.7m
USD
Based on the financial report for Jan 31, 2024, Champions Oncology Inc's Income from Continuing Operations amounts to -9.7m USD.
What is Champions Oncology Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-3%
Over the last year, the Income from Continuing Operations growth was -212%. The average annual Income from Continuing Operations growth rates for Champions Oncology Inc have been -113% over the past three years , -108% over the past five years , and -3% over the past ten years .